SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-012102
Filing Date
2018-05-09
Accepted
2018-05-09 07:01:45
Documents
95
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q reph-10q_20180331.htm 10-Q 1818939
2 EX-10.2 reph-ex102_215.htm EX-10.2 88431
3 EX-31.1 reph-ex311_9.htm EX-31.1 17429
4 EX-31.2 reph-ex312_104.htm EX-31.2 17286
5 EX-32.1 reph-ex321_6.htm EX-32.1 8131
  Complete submission text file 0001564590-18-012102.txt   8891986

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT reph-20180331.xml EX-101.INS 2065828
7 XBRL TAXONOMY EXTENSION SCHEMA reph-20180331.xsd EX-101.SCH 69337
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE reph-20180331_cal.xml EX-101.CAL 55674
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE reph-20180331_def.xml EX-101.DEF 271857
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE reph-20180331_lab.xml EX-101.LAB 532178
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE reph-20180331_pre.xml EX-101.PRE 451731
Mailing Address 490 LAPP ROAD MALVERN PA 19355
Business Address 490 LAPP ROAD MALVERN PA 19355 (484) 395-2400
Recro Pharma, Inc. (Filer) CIK: 0001588972 (see all company filings)

IRS No.: 261523233 | State of Incorp.: PA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36329 | Film No.: 18816628
SIC: 2834 Pharmaceutical Preparations